Brain-wide structural and functional disruption in mice with oligodendrocyte-specific <i>Nf1</i> deletion is rescued by inhibition of nitric oxide synthase.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32839340.
- Also identified by DOI 10.1073/pnas.2008391117 and PMC identifier 7486714.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neurofibromin gene (<i>NF1</i>) mutation causes neurofibromatosis type 1 (NF1), a disorder in which brain white matter deficits identified by neuroimaging are common, yet of unknown cellular etiology. In mice, <i>Nf1</i> loss in adult oligodendrocytes causes myelin decompaction and increases oligodendrocyte nitric oxide (NO) levels. Nitric oxide synthase (NOS) inhibitors rescue this pathology. Whether oligodendrocyte pathology is sufficient to affect brain-wide structure and account for NF1 imaging findings is unknown. Here we show that <i>Nf1</i> gene inactivation in adult oligodendrocytes (Plp-<i>Nf1</i><sup>fl/+</sup> mice) results in a motor coordination deficit. Magnetic resonance imaging in awake mice showed that fractional anisotropy is reduced in Plp-<i>Nf1</i><sup>fl/+</sup> corpus callosum and that interhemispheric functional connectivity in the motor cortex is also reduced, consistent with disrupted myelin integrity. Furthermore, NOS-specific inhibition rescued both measures. These results suggest that oligodendrocyte defects account for aspects of brain dysfunction in NF1 that can be identified by neuroimaging and ameliorated by NOS inhibition.
Medical subject headings
- Brain
- Neurofibromin 1
- Nitric Oxide Synthase
- Oligodendroglia